Literature DB >> 23866853

HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas.

Martin Holt.   

Abstract

This review assesses acceptability research for HIV pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) among men who have sex with men (MSM) in the Asia-Pacific region and the Americas, evaluating awareness and attitudes. There has been limited research on the acceptability of PrEP outside the United States and no research to date evaluating the acceptability of TasP since the findings of the HIV Prevention Trials Network 052 trial were released. Existing research suggests that PrEP is reasonably acceptable to MSM, but few men are likely to perceive the need for it. Studies of HIV treatment optimism suggest that MSM are likely to be sceptical of TasP.

Entities:  

Year:  2014        PMID: 23866853     DOI: 10.1071/SH13060

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  27 in total

1.  Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs.

Authors:  J Michael Wilkerson; Syed W Noor; Ellen D Breckenridge; Adeniyi A Adeboye; B R Simon Rosser
Journal:  AIDS Care       Date:  2015-04-02

2.  Exploring Patterns of Awareness and Use of HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men.

Authors:  Benjamin B Strauss; George J Greene; Gregory Phillips; Ramona Bhatia; Krystal Madkins; Jeffrey T Parsons; Brian Mustanski
Journal:  AIDS Behav       Date:  2017-05

3.  Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).

Authors:  Kristen Underhill; Kate M Guthrie; Christopher Colleran; Sarah K Calabrese; Don Operario; Kenneth H Mayer
Journal:  Arch Sex Behav       Date:  2018-01-11

4.  Gay Men's Understanding and Education of New HIV Prevention Technologies in Vancouver, Canada.

Authors:  Benjamin J Klassen; Nathan J Lachowsky; Sally Yue Lin; Joshua B Edward; Sarah A Chown; Robert S Hogg; David M Moore; Eric A Roth
Journal:  Qual Health Res       Date:  2017-07-01

5.  A Crowdsourced Physician Finder Prototype Platform for Men Who Have Sex with Men in China: Qualitative Study of Acceptability and Feasibility.

Authors:  Dan Wu; Wenting Huang; Peipei Zhao; Chunyan Li; Bolin Cao; Yifan Wang; Shelby Stoneking; Weiming Tang; Zhenzhou Luo; Chongyi Wei; Joseph Tucker
Journal:  JMIR Public Health Surveill       Date:  2019-10-08

6.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

7.  Intimacy, condom use, and pre-exposure prophylaxis (PReP) acceptability among men who have sex with men (MSM) in primary partnerships: a comment on Gamarel and Golub.

Authors:  Kristen Underhill
Journal:  Ann Behav Med       Date:  2015-04

8.  Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia.

Authors:  Jonathan M Galka; Melinda Wang; Iskandar Azwa; Britton Gibson; Sin How Lim; Roman Shrestha; Jeffrey A Wickersham
Journal:  Transgend Health       Date:  2020-12-11

Review 9.  Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.

Authors:  James Wilton; Heather Senn; Malika Sharma; Darrell Hs Tan
Journal:  HIV AIDS (Auckl)       Date:  2015-04-28

10.  Australian gay and bisexual men's attitudes to HIV treatment as prevention in repeated, national surveys, 2011-2013.

Authors:  Martin Holt; Toby Lea; Dean A Murphy; Jeanne Ellard; Marsha Rosengarten; Susan C Kippax; John B F De Wit
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.